More about

Leukemia

News
April 13, 2024
2 min read
Save

National Comprehensive Cancer Network appoints board of directors chair, vice chair

National Comprehensive Cancer Network appoints board of directors chair, vice chair

Matt Kalaycio, MD, FACP, has been elected chair of National Comprehensive Cancer Network’s board of directors.

News
March 28, 2024
3 min read
Save

Physicians express concerns about ‘ethical deployment’ of AI in clinical practice

Physicians express concerns about ‘ethical deployment’ of AI in clinical practice

The results from a nationwide survey, published in JAMA Network Open, highlight the complex issues oncologists are grappling with in integrating artificial intelligence.

News
March 27, 2024
4 min read
Save

‘We were shocked’: CAR-T rapidly reduces size of brain tumors in phase 1 trial

‘We were shocked’: CAR-T rapidly reduces size of brain tumors in phase 1 trial

A novel bivalent-targeting, intrathecally delivered chimeric antigen receptor T-cell therapy decreased tumor size in patients with recurrent glioblastoma, according to results from a phase 1 study published in Nature Medicine.

News
March 19, 2024
1 min read
Save

FDA grants accelerated approval to Iclusig for Philadelphia chromosome-positive ALL

FDA grants accelerated approval to Iclusig for Philadelphia chromosome-positive ALL

The FDA granted accelerated approval to ponatinib with chemotherapy for the treatment of adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia, according to a press release.

News
March 13, 2024
4 min read
Save

Risk factors identified for secondary leukemia in patients who received CAR T cells

Risk factors identified for secondary leukemia in patients who received CAR T cells

Researchers at Mayo Clinic have identified clinical factors associated with increased risk for developing myeloid neoplasms following chimeric antigen receptor T-cell therapy, according to data published in JAMA Oncology.

News
March 11, 2024
1 min read
Save

CAR-T shows ‘superior outcomes’ in adults with post-transplant relapsed leukemia

CAR-T shows ‘superior outcomes’ in adults with post-transplant relapsed leukemia

Patients with post-transplant relapsed B-cell acute lymphoblastic leukemia who received chimeric antigen receptor T-cell therapy had superior outcomes compared with alternative approaches, study results showed.

News
March 07, 2024
1 min read
Save

FDA approves Besponsa for certain pediatric patients with advanced leukemia

FDA approves Besponsa for certain pediatric patients with advanced leukemia

The FDA approved inotuzumab ozogamicin for use in pediatric patients with relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia, according to a press release.

News
February 26, 2024
2 min read
Save

Hollywood gets bad review for creating ’anxiety and fear’ through its portrayal of cancer

Hollywood gets bad review for creating ’anxiety and fear’ through its portrayal of cancer

David J. Benjamin, MD, recently met with a patient who recalled the moment a previous physician had diagnosed him with cancer.

News
January 26, 2024
4 min read
Save

Lack of resource ‘equality’ means research of the deadliest cancers is often underfunded

Lack of resource ‘equality’ means research of the deadliest cancers is often underfunded

Cancer research and advocacy funding disproportionately skewed toward certain subtypes, leaving many cancers with high mortality rates and those affecting Black patients underfunded, study results in JCO Oncology Practice showed.

News
January 09, 2024
2 min read
Save

Geriatric assessment in AML treatment selection may impact early mortality rates

Geriatric assessment in AML treatment selection may impact early mortality rates

SAN DIEGO — Personalizing treatment using both geriatric assessment and genetic profiling may decrease rates of early mortality among older patients with acute myeloid leukemia, according to a study from ASH Annual Meeting and Exposition.

View more